Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MC4R | P32245 | 8/20 | 0.59 |
| ▸ | GRPR | P30550 | 2/20 | 0.53 |
| ▸ | GHSR | Q92847 | 7/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20108329 | 0.95 | MC4R (0.57) | MC4RGRPRGHSR | |
| SCHEMBL23430224 | 0.94 | MC4R (0.59) | MC4RGRPRGHSR | |
| SCHEMBL20108414 | 0.94 | MC4R (0.59) | MC4RGRPRGHSR | |
| SCHEMBL23430159 | 0.93 | MC4R (0.58) | MC4RGRPRGHSR | |
| SCHEMBL20108498 | 0.92 | MC4R (0.57) | MC4RGRPRGHSR | |
| SCHEMBL19334877 | 0.90 | MC4R (0.55) | MC4RGRPRGHSR | |
| SCHEMBL20108277 | 0.90 | MC4R (0.61) | MC4RGRPRGHSR | |
| SCHEMBL20108413 | 0.89 | MC4R (0.59) | MC4RGRPRGHSR | |
| SCHEMBL20108311 | 0.89 | MC4R (0.59) | MC4RGRPRGHSR | |
| SCHEMBL20108360 | 0.88 | MC4R (0.53) | MC4RGRPRGHSR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210163536-A1 | MELANOCORTIN RECEPTOR LIGANDS MODIFIED WITH HYDANTOIN | IPSEN PHARMA SAS (FR) | 2021-06-03 | — | — | US | disclosed |
| US-20180118784-A1 | MELANOCORTIN RECEPTOR LIGANDS MODIFIED WITH HYDANTOIN | IPSEN PHARMA S.A.S. (FR) | 2018-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180118784-A1 | MELANOCORTIN RECEPTOR LIGANDS MODIFIED WITH HYDANTOIN | MC4R, MC3R, MC1R | MC4R 1/4885GRPR 31/4885GHSR 103/4885 |
| US-20210163536-A1 | MELANOCORTIN RECEPTOR LIGANDS MODIFIED WITH HYDANTOIN | MC4R, MC3R, MC1R | MC4R 1/4885GRPR 31/4885GHSR 103/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.